Ele Ferrannini
Overview
Explore the profile of Ele Ferrannini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
395
Citations
24044
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferrannini E, Baldi S, Scozzaro M, Ferrannini G, Hansen M
JCI Insight
. 2024 Dec;
9(24).
PMID: 39704168
BACKGROUNDSodium-glucose cotransporter 2 inhibitors slow down progression of chronic kidney disease (CKD). We tested whether the circulating substrate mix is related to CKD progression and cardiovascular outcomes in patients with...
2.
Ferrannini E, Solini A, Natali A
BMJ Open Diabetes Res Care
. 2024 Dec;
12(6.
PMID: 39631845
No abstract available.
3.
Campi B, Vitelli V, Saponaro F, Zucchi R, Ferrannini E, Saba A
Clin Chim Acta
. 2024 Oct;
565:120023.
PMID: 39471893
Recent studies have identified relationships between diabetes mellitus and short-chain fatty acids, including 2-hydroxybutyrate (2-HB) and 2-hydroxyisobutyrate (2-HiB); 2-HB has been associated to the early stages of insulin resistance, while...
4.
Willems S, Ng N, Fernandez J, Fine R, Wheeler E, Wessel J, et al.
Wellcome Open Res
. 2024 Sep;
8():483.
PMID: 39280063
Background: Genome-wide association studies for glycemic traits have identified hundreds of loci associated with these biomarkers of glucose homeostasis. Despite this success, the challenge remains to link variant associations to...
5.
Della Pepa G, Patricio B, Carli F, Sabatini S, Astiarraga B, Ferrannini E, et al.
Diabetes
. 2024 Jul;
73(10):1605-1614.
PMID: 38976482
Article Highlights:
6.
Latva-Rasku A, Rebelos E, Tuisku J, Aarnio R, Bhowmik A, Keskinen H, et al.
Diabetes Care
. 2024 Jun;
47(9):1630-1637.
PMID: 38941156
Objective: The aim of this study was to investigate the impact of the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin on tissue fatty acid (FA) uptake in the skeletal muscle, brain,...
7.
Trico D, Rebelos E, Astiarraga B, Baldi S, Scozzaro T, Sacchetta L, et al.
J Clin Endocrinol Metab
. 2024 Apr;
110(3):e667-e674.
PMID: 38635405
Context: Hypertriglyceridemia is a risk factor for developing type 2 diabetes (T2D) and might contribute to its pathogenesis either directly or through elevation of nonesterified fatty acids (NEFAs). Objective: This...
8.
Fortin E, Campi B, Ferrannini E, Mari A, Mellbin L, Norhammar A, et al.
Diabetes Care
. 2023 Dec;
47(2):246-251.
PMID: 38055929
Objective: To explore the associations among mannose, indexes of insulin resistance (IR) and secretion, and long-term cardiovascular outcomes. Research Design And Methods: Fasting mannose was assayed in 1,403 participants, one-half...
9.
Rebelos E, Mari A, Honka M, Pekkarinen L, Latva-Rasku A, Laurila S, et al.
J Clin Endocrinol Metab
. 2023 Nov;
109(4):1033-1040.
PMID: 37955868
Context: Studies on human renal metabolism are scanty. Nowadays, functional imaging allows the characterization of renal metabolism in a noninvasive manner. We have recently demonstrated that fluorodeoxyglucose F18 (18F FDG)...
10.
Ferrannini E, Solini A, Baldi S, Scozzaro T, Polidori D, Natali A, et al.
Diabetes
. 2023 Nov;
73(2):250-259.
PMID: 37939214
Article Highlights: